Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
Neonates delivered by scheduled Cesarean Section will be randomized to receive vaginal seeding (exposing the infant to Mother\'s vaginal flora) or sham. Infants will be followed for three years to examine health outcomes including microbiome development, immune development, metabolic outcomes, and any adverse events.
Epistemonikos ID: 0bbca9aed7b8f16d7ecc3d88c023744e09b794c4
First added on: Oct 03, 2023